Ocrelizumab use in the real-world experience: data from a hot spot area for Multiple Sclerosis

被引：0
|
作者：
Mellino, P. [1 ]
Lorefice, L. [1 ]
Pilotto, S. [1 ]
Frau, J. [1 ]
Pintus, M. [1 ]
Barca, S. [1 ]
Coghe, G. [1 ]
Barracciu, M. [2 ]
Cocco, E. [1 ]
机构：
[1] Univ Cagliari, Multiple Sclerosis Ctr, Dept Med Sci & Publ Hlth, ASL Cagliari,Binaghi Hosp, Cagliari, Italy
[2] ASL Cagliari, Binaghi Hosp, Radiol Unit, Cagliari, Italy
来源：
EUROPEAN JOURNAL OF NEUROLOGY | 2023年 / 30卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
EPO-497
引用
收藏
页码：634 / 635
页数：2
相关论文
共 50 条
  • [21] Safety and effectiveness of ocrelizumab in multiple sclerosis: a real-world study from spain
    Sempere, A.
    Berenguer-Ruiz, L.
    Burgos-San Jose, A.
    Aragones, M.
    Navarro-Lopez, M. D.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 553 - 553
  • [22] Real world study of ocrelizumab in multiple sclerosis: Kuwait experience
    Alroughani, Raed
    Almojel, Malak
    Al-Hashel, Jasem
    Ahmed, Samar Farouk
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 79
  • [23] Cladribine use in multiple sclerosis: a monocentric real-world experience
    Pilotto, Silvy
    Mellino, Paolo
    Carmagnini, Daniele
    Frau, Jessica
    Coghe, Giancarlo
    Cocco, Eleonora
    Lorefice, Lorena
    MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 639 - 640
  • [24] Evolution of teriflunomide use in multiple sclerosis: A real-world experience
    Lorefice, L.
    Pilotto, S.
    Fenu, G.
    Cimino, P.
    Firinu, D.
    Frau, J.
    Murgia, F.
    Coghe, G.
    Cocco, E.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 438
  • [25] Efficacy and safety of ocrelizumab in patients with relapsing multiple sclerosis: Real-world experience of two Swiss multiple sclerosis centers
    Diem, L.
    Ovchinnikov, A.
    Friedli, C.
    Hammer, H.
    Kamber, N.
    Chan, A.
    Salmen, A.
    Findling, O.
    Hoepner, R.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2024, 86
  • [26] Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience
    Cellerino, M.
    Boffa, G.
    Lapucci, C.
    Sbragia, E.
    Bruschi, N.
    Mancuso, E.
    Tazza, F.
    Poire, I.
    Laroni, A.
    Capello, E.
    Uccelli, A.
    Novi, G.
    Inglese, M.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 295 - 295
  • [27] Real-world experience with Ocrelizumab in Multiple Sclerosis patients: Two years follow up in Qatar
    Yousuf, Wajiha
    Ganesan, Gowrii Saswathy
    Humos, Basel
    Baig, Tehniyat
    Canibano, Beatriz
    Deleu, Dirk
    NEUROLOGY, 2021, 96 (15)
  • [28] Ocrelizumab treatment in patients with progressive multiple sclerosis: a single-center real-world experience
    Cellerino, Maria
    Boffa, Giacomo
    Lapucci, Caterina
    Sbragia, Elvira
    Bruschi, Nicolo
    Mancuso, Elisabetta
    Tazza, Francesco
    Poire, Ilaria
    Laroni, Alice
    Capello, Elisabetta
    Uccelli, Antonio
    Novi, Giovanni
    Inglese, Matilde
    NEUROLOGY, 2021, 96 (15)
  • [29] Real-World Results of Ocrelizumab Treatment for Primary Progressive Multiple Sclerosis
    Daniels, K.
    van der Nat, P. B.
    Frequin, S. T. F. M.
    van der Wees, P. J.
    Biesma, D. H.
    Hoogervorst, E. L. J.
    van de Garde, E. M. W.
    MULTIPLE SCLEROSIS INTERNATIONAL, 2020, 2020
  • [30] Real world experience with ocrelizumab in patients with primary progressive multiple sclerosis
    Lopez Ruiz, R.
    Dotor Garcia-Soto, J.
    Hiraldo, J. D. G.
    Ruiz-Pena, J. L.
    Paramo Camino, M. D.
    Ruiz De Arcos, M.
    Navarro Mascarell, G.
    Eichau Madueno, S.
    MULTIPLE SCLEROSIS JOURNAL, 2020, 26 (3_SUPPL) : 301 - 302
12345